Glioblastoma is an aggressive, unforgiving illness. Join us in demanding a new approach.
Glioblastoma is too often put in the ‘too difficult’ box. Survival rates have remained virtually the same for decades. We need more research, more urgency and more attention NOW.
13,000
PEOPLE ARE DIAGNOSED WITH GLIOBLASTOMA IN THE US EACH YEAR
5%
FIVE-YEAR SURVIVAL RATE
JUST
5%
OF RESEARCH FUNDING APPLICATIONS SUCCEED
13,000
PEOPLE ARE DIAGNOSED WITH GLIOBLASTOMA IN THE US EACH YEAR
The GBM Bill of Rights was developed by patients and ourselves, alongside our families and advocates.
GENOMIC TESTING.
Scientific advances like genomic testing and personalised medicine offer a way forward for people with GBM.
GBM DATA PROJECTS.
People with GBM are often left out of discussions about their own health journey. Our mission is to change this.
GBM BILL OF RIGHTS.
The GBM Bill of Rights was developed by patients and ourselves, alongside our families and advocates.
GENOMIC TESTING.
Scientific advances like genomic testing and personalised medicine offer a way forward for people with GBM.
MY DATA.
People with GBM are often left out of discussions about their own health journey. Our mission is to change this.
ADVOCATING FOR GBM
GBM receives too little attention and resources. A big part of what OurBrainBank does involves patient advocacy and raising awareness for GBM.
Through our patient-centred advocacy, we hope to inspire institutional, financial, medical and regulatory reform. Our GBM Bill of Rights, developed by those affected by GBM, is designed to empower people and inspire them to call for a better approach to GBM care.
Together with our allies and partners in other GBM and brain tumor organisations, we know that we are stronger together than apart. If we join forces we can ensure people with GBM have their voices heard.
Through our patient-centred advocacy, we hope to inspire institutional, financial, medical and regulatory reform. Our GBM Bill of Rights, developed by those affected by GBM, is designed to empower people and inspire them to call for a better approach to GBM care.
Together with our allies and partners in other GBM and brain tumor organisations, we know that we are stronger together than apart. If we join forces we can ensure people with GBM have their voices heard.
GBM BILL OF RIGHTS
The GBM Bill of Rights is our people-centered call to action. Developed by patients, alongside our families and advocates, this is the roadmap to patient power and a brighter future.
SUPPORT US
We need help developing the technology and recruiting people onto our new project. Please help us pave the way for more patient data-led research into GBM.
GBM BILL OF RIGHTS
The GBM Bill of Rights is our people-centered call to action. Developed by patients, alongside our families and advocates, this is the roadmap to patient power and a brighter future.
SUPPORT US
We need help developing the technology and recruiting people onto our new project. Please help us pave the way for more patient data-led research into GBM.
TARGETED CAMPAIGNS
OBB plans to focus on each one of the points flagged up in the GBM Bill of Rights and push for its fulfillment. We will not rest until we see improvements in each of the 11 rights.
OurBrainBank’s glioblastoma survey found younger respondents (under 50) had a longer wait as did urban residents.
We’re presenting these findings and others at the ASCO Quality Care Symposium in Boston, October 2026.
Lakshmi Nayak, MD, of Dana-Farber Cancer Institute. Dr. Nayak explains LIFT — Life Insights From Technology — and how researchers are exploring daily-life patterns and social support for people with GBM and their care partners.
The FDA has approved Pixclara®, the first FDA-approved FET-PET imaging drug for glioma. Here’s what the approval may mean for patients and care partners.
My mother-in-law Karla told me she had a brain tumor before she told my wife Michelle. Karla and Michelle were inseparable. Karla had Michelle at just 18, so in many ways, they grew up together. Michelle shared everything with her mom because Karla was her best friend…
OurBrainBank’s glioblastoma survey found younger respondents (under 50) had a longer wait as did urban residents.
We’re presenting these findings and others at the ASCO Quality Care Symposium in Boston, October 2026.
Lakshmi Nayak, MD, of Dana-Farber Cancer Institute. Dr. Nayak explains LIFT — Life Insights From Technology — and how researchers are exploring daily-life patterns and social support for people with GBM and their care partners.
The FDA has approved Pixclara®, the first FDA-approved FET-PET imaging drug for glioma. Here’s what the approval may mean for patients and care partners.
My mother-in-law Karla told me she had a brain tumor before she told my wife Michelle. Karla and Michelle were inseparable. Karla had Michelle at just 18, so in many ways, they grew up together. Michelle shared everything with her mom because Karla was her best friend…
We use cookies to improve your experience and analyze site traffic. By clicking “Accept,” you consent to our use of cookies. Learn more in our Privacy Policy.